Fairfield Financial Advisors’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-125
Closed -$7.11K 100
2024
Q4
$7.11K Buy
125
+1
+0.8% +$59 ﹤0.01% 214
2024
Q3
$7.32K Hold
124
﹤0.01% 235
2024
Q2
$6.69K Buy
+124
New +$6.83K ﹤0.01% 231
2023
Q4
$5.91K Hold
123
﹤0.01% 262
2023
Q3
$6.29K Hold
123
﹤0.01% 248
2023
Q2
$7.02K Buy
123
+1
+0.8% +$58 ﹤0.01% 260
2023
Q1
$7.33K Hold
122
﹤0.01% 262
2022
Q4
$7.16K Hold
122
﹤0.01% 240
2022
Q3
$6.95K Buy
122
+1
+0.8% +$58 ﹤0.01% 242
2022
Q2
$6.57K Hold
121
﹤0.01% 231
2022
Q1
$6.95K Buy
+121
New +$6.18K ﹤0.01% 244

Other funds holding CTVA

Fairfield Financial Advisors's CTVA Position: Q1 2025 in Review

Fairfield Financial Advisors sold out of Corteva (CTVA) in Q1 2025, closing a stake of 125 shares — an estimated $7.11K sold.

Fairfield Financial Advisors first reported a position in CTVA in Q1 2022 and held it in 11 quarters. The position peaked at $7.33K in Q1 2023. 1,322 funds tracked by Wall St. Rank hold CTVA as of Q1 2025.

  • Fairfield Financial Advisors reported no remaining Corteva position as of Q1 2025 after selling out during the quarter.
  • Fairfield Financial Advisors sold 125 Corteva shares in Q1 2025, an estimated $7.11K.
  • Fairfield Financial Advisors first reported a position in Corteva in Q1 2022 and held it in 11 quarters.
  • Fairfield Financial Advisors's Corteva position peaked at $7.33K in Q1 2023.
  • 1,322 funds tracked by Wall St. Rank held Corteva as of Q1 2025.

Based on Fairfield Financial Advisors's 13F filing for Q1 2025, filed 9 May 2025.